Fibroblast growth factor 23 decreases PDE4 expression in heart increasing the risk of cardiac arrhythmia; Klotho opposes these effects
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast growth factor 23 decreases PDE4 expression in heart increasing the risk of cardiac arrhythmia; Klotho opposes these effects
Authors
Keywords
-
Journal
BASIC RESEARCH IN CARDIOLOGY
Volume 115, Issue 5, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-22
DOI
10.1007/s00395-020-0810-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble klotho regulates TRPC6 calcium signaling via lipid rafts, independent of the FGFR-FGF23 pathway
- (2019) Jon D. Wright et al. FASEB JOURNAL
- FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice
- (2019) Xiaobin Han et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Lower soluble Klotho and higher fibroblast growth factor 23 serum levels are associated with episodes of atrial fibrillation
- (2018) Katarzyna Mizia-Stec et al. CYTOKINE
- α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling
- (2018) Gaozhi Chen et al. NATURE
- The Klotho proteins in health and disease
- (2018) Makoto Kuro-o Nature Reviews Nephrology
- Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes
- (2018) José Alberto Navarro-García et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Chronic Kidney Disease
- (2017) Angela C Webster et al. LANCET
- Biology of Fibroblast Growth Factor 23: From Physiology to Pathology
- (2017) Marie Courbebaisse et al. Cold Spring Harbor Perspectives in Medicine
- Prognostic value of FGF23 among patients with end-stage renal disease: a systematic review and meta-analysis
- (2016) Hongliu Yang et al. Biomarkers in Medicine
- Calmodulin kinase II inhibition limits the pro-arrhythmic Ca2+waves induced by cAMP-phosphodiesterase inhibitors
- (2016) Pierre Bobin et al. CARDIOVASCULAR RESEARCH
- The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
- (2016) Alexander Grabner et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- High serum soluble α-Klotho levels in patients with autosomal dominant polycystic kidney disease
- (2016) Funda Sari et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study
- (2016) Rupal Mehta et al. JAMA Cardiology
- Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages
- (2016) Suguru Tanaka et al. PLoS One
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction
- (2015) Lorenz Koller et al. Circulation-Heart Failure
- Upregulation of KCNQ1/KCNE1 K+channels by Klotho
- (2014) Ahmad Almilaji et al. Channels
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients
- (2014) Albina Nowak et al. PLoS One
- Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
- (2014) Pamela L. Lutsey et al. Journal of the American Heart Association
- Differential regulation of cardiac excitation–contraction coupling by cAMP phosphodiesterase subtypes
- (2013) Delphine Mika et al. CARDIOVASCULAR RESEARCH
- Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury
- (2013) Masayoshi Oikawa et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure
- (2013) Tamara Isakova et al. PEDIATRIC NEPHROLOGY
- Plasma Fibroblast Growth Factor 23 Concentration Is Increased and Predicts Mortality in Patients on the Liver-Transplant Waiting List
- (2013) Dominique Prié et al. PLoS One
- Fibroblast Growth Factor Receptor 1 Signaling in Adult Cardiomyocytes Increases Contractility and Results in a Hypertrophic Cardiomyopathy
- (2013) Sarah N. Cilvik et al. PLoS One
- Phosphoinositide 3-Kinase γ Protects Against Catecholamine-Induced Ventricular Arrhythmia Through Protein Kinase A–Mediated Regulation of Distinct Phosphodiesterases
- (2012) Alessandra Ghigo et al. CIRCULATION
- Role of RyR2 Phosphorylation at S2814 During Heart Failure Progression
- (2012) Jonathan L. Respress et al. CIRCULATION RESEARCH
- Phosphodiesterase Type 3A Regulates Basal Myocardial Contractility Through Interacting With Sarcoplasmic Reticulum Calcium ATPase Type 2a Signaling Complexes in Mouse Heart
- (2012) Sanja Beca et al. CIRCULATION RESEARCH
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Cyclic Adenosine Monophosphate Phosphodiesterase Type 4 Protects Against Atrial Arrhythmias
- (2012) Cristina E. Molina et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- C-terminal FGF23 is a strong predictor of survival in systolic heart failure
- (2012) Damien Gruson et al. PEPTIDES
- Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
- (2012) Jian Xie et al. Nature Communications
- Cardiac Sarcoplasmic Reticulum Calcium Leak: Basis and Roles in Cardiac Dysfunction
- (2011) Donald M. Bers Annual Review of Physiology
- Soluble Klotho and Autosomal Dominant Polycystic Kidney Disease
- (2011) I. Pavik et al. Clinical Journal of the American Society of Nephrology
- Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure
- (2011) Max Plischke et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- A mTurquoise-Based cAMP Sensor for Both FLIM and Ratiometric Read-Out Has Improved Dynamic Range
- (2011) Jeffrey B. Klarenbeek et al. PLoS One
- Ryanodine Receptor Phosphorylation by Calcium/Calmodulin-Dependent Protein Kinase II Promotes Life-Threatening Ventricular Arrhythmias in Mice With Heart Failure
- (2010) Ralph J. van Oort et al. CIRCULATION
- Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule
- (2010) Ming Chang Hu et al. FASEB JOURNAL
- Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease
- (2010) Hisashi Hasegawa et al. KIDNEY INTERNATIONAL
- Regulation of ion channels by secreted Klotho: mechanisms and implications
- (2010) Chou-Long Huang KIDNEY INTERNATIONAL
- Decreased Expression and Activity of cAMP Phosphodiesterases in Cardiac Hypertrophy and Its Impact on β-Adrenergic cAMP Signals
- (2009) Aniella Abi-Gerges et al. CIRCULATION RESEARCH
- Spatiotemporal Dynamics of β-Adrenergic cAMP Signals and L-Type Ca 2+ Channel Regulation in Adult Rat Ventricular Myocytes
- (2008) Jérôme Leroy et al. CIRCULATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started